Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
The evidence for interleukin-6 as an autocrine growth factor in malignancy. — Akira Shizuo (1992) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
The evidence for interleukin-6 as an autocrine growth factor in malignancy.
Shared by
Akira Shizuo
Osaka University
The evidence for interleukin-6 as an autocrine growth factor in malignancy.
Article
1992
en
Related publications
Article
1992
The evidence for interleukin-6 as an autocrine growth factor in malignancy.
Akira Shizuo
,
Tadamitsu Kishimoto
PubMed
Article
1996
IL-6 is an in vitro and in vivo autocrine growth factor for middle T antigen-transformed endothelial cells
Enrico Giraudo
,
Marco Arese
,
Carlo Toniatti
,
Marina Strasly
,
Luca Primo
,
Authors
Akira Shizuo
Osaka University
TK
Tadamitsu Kishimoto
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Alberto Mantovani
,
Gennaro Ciliberto
,
F Bussolini
Article
2004
A Novel Role for Vascular Endothelial Growth Factor as an Autocrine Survival Factor for Embryonic Stem Cells during Hypoxia
Koen Brusselmans
,
Françoise Bono
,
Désiré Collen
,
Jean‐Marc Herbert
,
Peter Carmeliet
,
Mieke Dewerchin
Article
2006
Placental growth factor induces osteoclast differentiation by an autocrine and paracrine pathway
Lieve Coenegrachts
,
Evis Daci
,
Sophie Torrekens
,
Jean–Marie Stassen
,
Roger Bouillon
,
Peter Carmeliet
,
Geert Carmeliet
Article
2003
Regulation of Hypoxia-Inducible Factor-1α, Vascular Endothelial Growth Factor, and Angiogenesis by an Insulin-Like Growth Factor-I Receptor Autocrine Loop in Human Pancreatic Cancer
Oliver Stoeltzing
,
Wenbiao Liu
,
Niels Reinmuth
,
Fan Fan
,
Alexander A. Parikh
,
Corazon D. Bucana
,
Douglas B. Evans
,
Gregg L. Friedman
,
Lee M. Ellis
.jpg){kind=small}
Discussion(0)
No comments yet. Be the first to comment.